Systematic Pan-Cancer Analysis of KIF23 and a Prediction Model Based on KIF23 in Clear Cell Renal Cell Carcinoma (ccRCC)
Xiaojie Bai,Yuanfei Cao,Xin Yan,Kurerban Tuoheti,Guowei Du,Zhao Chen,Huahui Wu,Linfa Guo,Tongzu Liu
DOI: https://doi.org/10.2147/PGPM.S337695
2021-12-30
Pharmacogenomics and Personalized Medicine
Abstract:Xiaojie Bai, Yuanfei Cao, Xin Yan, Kurerban Tuoheti, Guowei Du, Zhao Chen, Huahui Wu, Linfa Guo, Tongzu Liu Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China Correspondence: Tongzu Liu Department of Urology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan, 430071, People's Republic of China Tel +86-27-67813104 Fax +86-27-67812667 Email Purpose: This study aims to carry out a pan-cancer analysis of kinesin family member 23 (KIF23) and construct a predictive model for the prognosis of clear cell renal cell carcinoma (ccRCC) patients. Methods: We evaluated the differential expression of KIF23 in pan-cancer by The Cancer Genome Atlas (TCGA) and Oncomine database. Then, the correlation between KIF23 with prognosis, clinical grade, stage, immune subtype, tumor mutation burden (TMB), microsatellite instability (MSI) and immune microenvironment was explored by TCGA, an integrated repository portal for tumor-immune system interactions (TISIDB) and cBioPortal. Subsequently, we screened out ferroptosis-related genes (FRGs) related to KIF23 and constructed a risk score model. Univariate Cox analysis was used to determine independent prognostic factors for ccRCC overall survival (OS), and a nomogram was established. Furthermore, gene set enrichment analysis (GSEA) was applied to study the biological functions and pathways of KIF23. Finally, quantitative real-time polymerase chain reaction (qRT-PCR) was carried out to evaluate the expression of KIF23. Results: KIF23 was highly expressed in most tumors. Further, KIF23 was strongly correlated with prognosis, clinical grade, stage, immune subtype, TMB, MSI and immune microenvironment in different tumors. We found that KIF23 was significantly associated with all aspects of ccRCC. Then, 8 FRGs were identified to construct a risk score model together with KIF23. And a prognostic nomogram prediction model of OS was established. After GSEA analysis, cell cycle, condensed chromosome and other physiological processes were screened out. Finally, qRT-PCR verified the high expression of KIF23 in ccRCC cell lines than normal kidney cell line. Conclusion: KIF23 may act as a pivotal part in occurrence and progression of different tumors. In ccRCC, KIF23 can be a great prognostic biomarker, and the nomogram based on KIF23 may contribute to better treatment plans for ccRCC patients. Keywords: clear cell renal cell carcinoma, ferroptosis, nomogram According to the latest Global Cancer Statistics, the incidence of renal cell carcinoma (RCC) ranks 12th, with approximately 74,000 new cases in the United States in 2020. 1 Clear cell renal cell carcinoma (ccRCC) accounts for 70–80% of all RCC and is one of the most aggressive pathological type. 2 For localized ccRCC, surgical interventions are the best options. 3 However, about 30% of renal cancer patients already present with metastasis at the time of initial diagnosis since there are no obvious symptoms in the early stage. 4 One quarter of surgically treated patients will eventually develop cancer recurrence and metastasis. 5 Although treatment options have advanced a lot, the prognosis of this disease remains poor, especially for patients with advanced stages. 6 Therefore, this calls for exploration of more effective prognostic biomarkers and construction of more accurate prognostic models to provide better treatment decisions. Kinesin family member 23 (KIF23), also called MKLP1, is the human homolog of mouse KIF23. Previous research indicated that KIF23 played an important role in regulation of cytokinesis. 7 Dysfunction of KIF23 led to mitotic arrest and the generation of binucleated or multinucleated cells, resulting in the appearance of tumors. 8 Previous studies have also shown that KIF23 was highly expressed in a variety of tumors and was correlated with cancer progression, such as gastric cancer, 9 gliomas 10 and breast cancer. 11 Knockdown of KIF23 suppressed proliferation of pancreatic ductal adenocarcinoma cells. 12 These studies suggested that KIF23 may be an ideal prognostic and therapeutic pan-cancer biomarker. Ferroptosis is a novel form of iron-dependent regulated cell death, which is different from apoptosis and autophagy. The key characteristic of Ferroptosis is the accumulation of excessive reactive oxygen species (ROS) and abnormal iron metabolism. Increasing evidence has shown that Ferroptosis is involved in the progression and metastasis of cancers. Meanwhile, Ferroptosis has also became a potential target for cancer therapy. In this study, we utilized the TCGA database and Oncomine to evaluate the differential expression and the prognosis va -Abstract Truncated-
pharmacology & pharmacy